RLAYRelay Therapeutics, Inc.
$18.17+179% 1Y
$18.17
$6.0552 weeks$20.77
Is it growing?
Good
1 good, 2 without dataRevenue growing +24% year on year. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Revenue trend+24% in a yearSEC EDGAR · Jun 30, 2026
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is RLAY growing?
Relay Therapeutics, Inc.'s revenue has grown 122% a year over three years.
+122%
Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue
- Years of annual history on file
- 7
Years of annual history on file · FY2019 to FY2025, as filed
Details›
- Revenue FY2021
- $3.0M
- Revenue FY2022
- $1.4M
- Revenue FY2023
- $26M
- Revenue FY2024
- $10M
- Revenue FY2025
- $15M
Annual income statements as filed with the SEC.
On our screens:Most shorted stocks